⟵ Back to Search Results
BGB-3111-304

Active, not recruiting

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

Beigene Study ID info

BGB-3111-304

ClinicalTrials.gov ID info

NCT03336333

EudraCT Number info

2017-001551-31

China Drug Trials ID info

CTR20190416

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan